GG
Gleason Group Portfolio holdings
AUM
$923M
This Quarter Return
+6.41%
1 Year Return
+13.47%
3 Year Return
+56.47%
5 Year Return
+87.83%
10 Year Return
–
AUM
$546M
AUM Growth
+$53.5M
(+11%)
Cap. Flow
+$22.8M
Cap. Flow
% of AUM
4.17%
Top 10 Holdings %
Top 10 Hldgs %
83.75%
Holding
272
New
3
Increased
97
Reduced
48
Closed
81
Top Buys
| 1 |
Vanguard Extended Market ETF
VXF
|
$7.24M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$6.06M |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
$4.48M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
$4.33M |
| 5 |
Vanguard Value ETF
VTV
|
$1.12M |
Top Sells
| 1 |
Walt Disney
DIS
|
$695K |
| 2 |
Nike
NKE
|
$572K |
| 3 |
iShares S&P 500 Growth ETF
IVW
|
$313K |
| 4 |
Intel
INTC
|
$223K |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
$198K |
Sector Composition
| 1 | Financials | 1.75% |
| 2 | Consumer Staples | 1.67% |
| 3 | Industrials | 1.41% |
| 4 | Consumer Discretionary | 1.16% |
| 5 | Technology | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Allstate
ALL
$54.7B
| $34.7K | 0.01% |
183
+1
| +0.5% | +$190 |
|
127
NVIDIA
NVDA
$4.14T
| $34.1K | 0.01% |
280
| – | – |
|
128
Vanguard Information Technology ETF
VGT
$98.6B
| $33.7K | 0.01% |
58
-18
| -24% | -$10.5K |
|
129
Pfizer
PFE
$140B
| $33.6K | 0.01% |
1,161
-522
| -31% | -$15.1K |
|
130
Textron
TXT
$14.3B
| $33.3K | 0.01% |
376
| – | – |
|
131
AT&T
T
$211B
| $31.5K | 0.01% |
1,433
-295
| -17% | -$6.49K |
|
132
FedEx
FDX
$52.8B
| $29.7K | 0.01% |
109
+1
| +0.9% | +$273 |
|
133
Direxion NASDAQ-100 Equal Weighted Index Shares
QQQE
$1.19B
| $28.5K | 0.01% |
316
-9
| -3% | -$811 |
|
134
Dimensional US Small Cap ETF
DFAS
$11.2B
| $26K | ﹤0.01% |
401
+1
| +0.3% | +$65 |
|
135
Snap-on
SNA
$16.8B
| $25.5K | ﹤0.01% |
88
+1
| +1% | +$290 |
|
136
Vanguard Energy ETF
VDE
$7.3B
| $25.5K | ﹤0.01% |
208
+2
| +1% | +$245 |
|
137
Brown-Forman Class A
BF.A
$13.6B
| $25.4K | ﹤0.01% |
529
+3
| +0.6% | +$144 |
|
138
US Bancorp
USB
$75.9B
| $23.3K | ﹤0.01% |
509
-132
| -21% | -$6.03K |
|
139
Vanguard FTSE Developed Markets ETF
VEA
$170B
| $22.5K | ﹤0.01% |
426
-430
| -50% | -$22.7K |
|
140
Invesco S&P 500 Pure Growth ETF
RPG
$1.71B
| $22.3K | ﹤0.01% |
569
+1
| +0.2% | +$39 |
|
141
Invesco S&P 500 Pure Value ETF
RPV
$1.35B
| $21.3K | ﹤0.01% |
239
+1
| +0.4% | +$89 |
|
142
iShares Morningstar Mid-Cap Value ETF
IMCV
$824M
| $20K | ﹤0.01% |
261
+2
| +0.8% | +$153 |
|
143
iShares MSCI EAFE ETF
EFA
$65.7B
| $19.5K | ﹤0.01% |
233
| – | – |
|
144
Eversource Energy
ES
$23.5B
| $19.1K | ﹤0.01% |
280
-60
| -18% | -$4.09K |
|
145
AbbVie
ABBV
$378B
| $17.6K | ﹤0.01% |
89
-29
| -25% | -$5.72K |
|
146
Orion Group Holdings
ORN
$290M
| $17K | ﹤0.01% |
2,952
| – | – |
|
147
Marsh & McLennan
MMC
$101B
| $16.9K | ﹤0.01% |
76
+1
| +1% | +$222 |
|
148
Elevance Health
ELV
$70.5B
| $16.1K | ﹤0.01% |
31
-7
| -18% | -$3.63K |
|
149
MiMedx Group
MDXG
$1.05B
| $16K | ﹤0.01% |
2,712
| – | – |
|
150
United Bankshares
UBSI
$5.42B
| $16K | ﹤0.01% |
432
+5
| +1% | +$185 |
|